Literature DB >> 9261287

Strategies to protect bone mass in the older patient with epilepsy.

A Cohen1, M Lancman, H Mogul, S Marks, K Smith.   

Abstract

The annual incidence of epileptic seizures rises dramatically after the age of 60. Risk factors associated with late-onset epilepsy include cerebrovascular disease, dementia, infection, trauma, and alcoholism. The dominant cause of seizures in older patients is a previous stroke, whereas a significant percentage of cases are attributed to the presence of a tumor. Normal aging is associated with an increased risk for fractures from trauma and osteoporosis. Antiepileptic medications may exacerbate this problem by adversely affecting bone metabolism and increasing the risk of falls related to drug toxicity. The patient work-up, careful prescribing, and monitoring for drug toxicity can help preserve bone integrity in patients receiving antiepileptic drug therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261287

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  5 in total

1.  Preventing fractures among people with developmental disabilities.

Authors:  H Mogul
Journal:  West J Med       Date:  1999-08

2.  Use of osteoporosis medications in older nursing facility residents.

Authors:  Rollin M Wright
Journal:  J Am Med Dir Assoc       Date:  2007-08-13       Impact factor: 4.669

Review 3.  Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.

Authors:  Sandra J Petty; Helen Wilding; John D Wark
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

4.  The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure.

Authors:  Mary Jo Pugh; Dan R Berlowitz; Jaya K Rao; Gabriel Shapiro; Ruzan Avetisyan; Amresh Hanchate; Kelli Jarrett; Jeffrey Tabares; Lewis E Kazis
Journal:  BMC Health Serv Res       Date:  2011-01-03       Impact factor: 2.655

5.  Aging and bone health in individuals with developmental disabilities.

Authors:  Joan Jasien; Caitlin M Daimon; Stuart Maudsley; Bruce K Shapiro; Bronwen Martin
Journal:  Int J Endocrinol       Date:  2012-07-22       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.